Voloridge Investment Management
FBRX icon

Voloridge Investment Management’s Forte Biosciences FBRX Stock Holding History

Voloridge Investment Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,045
Closed -$77K – 1642
2021
Q3 		$77K Buy
+1,045
New +$579K ﹤0.01% 1607

Other funds holding FBRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Voloridge Investment Management's FBRX Position: Q4 2021 in Review

Voloridge Investment Management sold out of Forte Biosciences (FBRX) in Q4 2021, closing a stake of 1,045 shares — an estimated $77K sold.

Voloridge Investment Management first reported a position in FBRX in Q3 2021 and held it in 1 quarter. The position peaked at $77K in Q3 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q4 2021.

  • Voloridge Investment Management reported no remaining Forte Biosciences position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 1,045 Forte Biosciences shares in Q4 2021, an estimated $77K.
  • Voloridge Investment Management first reported a position in Forte Biosciences in Q3 2021 and held it in 1 quarter.
  • Voloridge Investment Management's Forte Biosciences position peaked at $77K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.